MEDIA ADVISORY
CONTACTS:
ChristianaCare
Contact:
Megan McGuriman, 215-264-0583
megan.n.mcguriman@christianacare.org
The Franklin Institute Contact:
Stefanie Santo, 215-448-1152
ssanto@fi.edu
Media Advisory
DETV
to air live panel discussion on
Building
Trust: Eliminating Disparities in Clinical Trials
Thursday,
May 13, 7-8:30 p.m.
The Franklin Institute and ChristianaCare’s Gene Editing Institute event discusses
ethics and explores solutions to improve racial and ethnic diversity in
clinical trials
What: Experts discuss the key
issues on how to build trust to improve racial and ethnic diversity in clinical trials.
New life-saving medical
treatments and therapies are being developed for diseases from cancer to COVID.
However, a major barrier to helping everyone is that clinical trials – the
process by which these new treatments are tested to make sure they are safe and
effective – do not involve everyone. Improving racial and ethnic diversity in
clinical trials would help us discover better medicines for more people, yet
there are many real challenges to doing so. How can we, as a community, work
together to fix this moral, medical, and scientific problem?
Note: Watch a pre-recorded interview here: Jayatri
Das, Ph.D., chief bioscientist at The Franklin
Institute, with Ivan Thomas of
DETV discuss how to build trust to eliminate disparities in clinical trials.
Who: Jayatri Das, Ph.D., Chief
Bioscientist, The Franklin Institute
Ivan Thomas, Founder, DETV
Eric Kmiec, Ph.D., Director
of the Gene Editing Institute at ChristianaCare
Jacqueline Crawford, RN, patient/participant
in a breast cancer clinical trial
Anya Harry, M.D., Ph.D., Global
Lead Clinical Trial Diversity, GlaxoSmithKline
Holly Fernandez Lynch, JD, MBioethics, John Russell Dickson, M.D., Presidential
Assistant Professor of Medical Ethics, Perelman School of Medicine, University
of Pennsylvania
When: Thursday, May 13, 7-8:30 p.m.
Where Watch DETV for a live panel discussion with
scientists, experts, and community members.